Delivery Order SPE2DB20D3104-SPE2DB22FV8P2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.23, is for the delivery of AMITIZA 24 MCG CAPSULES 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,494.82 firm fixed-price delivery order is for the supply of Amitiza 8 MCG capsules. The contract has an ultimate completion date of April 6, 2023 and was awarded on April 5, 2023. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Amitiza 24 MCG capsules. The award ceiling value is $2,888.42 and the ultimate completion date is April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,143.23 delivery order is for Amitiza 24 MCG capsules and is under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of Lubiprostone 24 MCG Capsule 60s, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The ceiling value of the delivery order is $2,372.99, with a firm fixed price. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.78 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Lubiprostone 24 MCG capsules. The contract is valued at $5,720.58 and has a completion date of February 15, 2022. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of LINZESS 145 MCG capsules to DLA Troop Support Medical, with a ceiling value of $1,198.63 and a performance period through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the prescription medication LINZESS 72 MCG CAPSULE UU 30S. The firm-fixed-price contract has a ceiling value of $7,590.99 and a completion date of July 2, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of LINZESS 290 MCG CAPSULE in quantities of 30s, with a firm fixed price of $11,513.57 and a completion date of September 19, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this order is part of...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV8P2Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMITIZA 24 MCG CAPSULES 60S. The contract has a ceiling value of $7,934.42 and a completion date of August 4, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/3/22 |